296 A comprehensive clinical and genomic characterization of long-term responders receiving immune checkpoint blockade for metastatic non-small cell lung cancer

• Patrick Forde,
• Julie Brahmer,
• Vincent Lam,
• Christine Hann,
• Melinda Hsu,
• Josephine Feliciano,
• Kristen Marrone,
• Joseph Murray,
• Paola Ghanem,
• David Ettinger,
• Benjamin Levy

Affiliations

Patrick Forde

Aff1 grid.7872.a0000000123318773Cork Cancer Research Centre Cork City Ireland

Julie Brahmer

Aff1 grid.21107.350000000121719311Sidney Kimmel Comprehensive Cancer Center at John Hopkins University Baltimore MD USA

Vincent Lam

1MD Anderson Cancer Center, Houston, TX, USA

Christine Hann

Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA

Melinda Hsu

Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA

Josephine Feliciano

Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA

Kristen Marrone

Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA

Joseph Murray

Postgraduate Program in Epidemiology, Department of Social Medicine, Federal University of Pelotas, Pelotas, RS, Brazil

Paola Ghanem

1Johns Hopkins University, Baltimore, MD, USA

David Ettinger

1Johns Hopkins University, Baltimore, MD, USA

Benjamin Levy

1Johns Hopkins University, Baltimore, MD, USA